JC124 was shown to block ASC aggregation, caspase-1 activation, and IL-1β secretion and thus exert protective effects in the mouse models of acute myocardial infarction (Fulp et al. 2018) and in transgenic AD models (Yin et al. 2018). This evidence concerns the gene IL1B and myocardial infarction.